Deficiencies

C Coenzyme Q10 Nutripedia entry ↗ vitamineria.com

Primary coenzyme Q10 deficiency: causes, symptoms and diagnosis

It is a group of rare inherited diseases in which a genetic mutation prevents cells from producing enough of their own coenzyme Q10. It is unrelated to eating too little CoQ10 or to the decline caused by age or statins: it is a failure of internal production present from birth.

Also known as: coenzyme Q10 deficiency syndrome, primary CoQ10 deficiency, ubiquinone deficiency

On this page · 9

What it is

Primary coenzyme Q10 deficiency (also referred to as coenzyme Q10 deficiency syndrome) is not a nutritional deficiency but a group of rare genetic diseases caused by biallelic recessive mutations in one of the COQ genes required in the CoQ10 biosynthesis pathway, at enzymatic or regulatory level. Coenzyme Q10 is a molecule synthesised in the body’s own cells that has essential functions in cellular metabolism; among its best-known roles are its part in producing the energy the cell needs and its antioxidant capacity.

Causes

The disease arises from mutations inherited from both parents in genes such as PDSS1, PDSS2, COQ2, COQ4, COQ5, COQ6, COQ7, COQ8A, COQ8B or COQ9. As with any autosomal recessive disease, it is inherited in an autosomal recessive pattern, which means that both copies of the gene in each cell must carry the mutations for the disorder to be expressed; parents usually carry only one mutated copy and generally show no signs or symptoms.

The first thing you notice Symptoms

Severity, the combination of signs and symptoms and age of onset vary widely from one patient to another, even within the same family. The forms described include:

  • Muscle weakness with episodes of dark urine after physical exertion
  • Cerebellar ataxia (loss of coordination when walking), the most common presentation
  • Severe multisystem forms in infants, affecting several organs at once
  • Steroid-resistant nephrotic syndrome in forms linked to certain genes
  • Isolated muscle weakness in the mildest forms
  • Seizures in some cases

At organ level, the associated clinical manifestations are highly heterogeneous and mainly affect the central and peripheral nervous system, the kidneys, skeletal muscle and the heart. Researchers from CIBERER at Pablo de Olavide University (Seville) also note that primary coenzyme Q10 deficiency damages organs that are particularly dependent on energy availability, such as the brain, muscles, liver or kidneys, and can cause muscle weakness, kidney failure, ataxia, hearing loss and epilepsy, among other clinical signs. In the most severe cases, bioenergetic inefficiency leads to the death of many cells, causing organ collapse, and in the long term the disease is debilitating and sometimes fatal, particularly due to kidney failure, muscular limitations and encephalopathy.

Who it affects most Who is at risk
  • Children of two parents who carry a mutation in the same COQ gene (autosomal recessive pattern)
  • Families with a sibling already diagnosed with this disease

It is a rare disease: it has an approximate prevalence of 1 in every 100,000 people, equivalent to a total of around 5,000 citizens across the European Union, and the primary forms mainly affect children and adolescents.

What the laboratory says How the diagnosis is confirmed

Diagnosis combines two parts. On the one hand, genetic testing: in Spain, specialised laboratories detect mutations associated with primary coenzyme Q10 deficiency by complete PCR amplification of the exons of the COQ2, COQ4, COQ6, COQ8A and COQ8B genes, followed by sequencing, usually from EDTA blood. On the other hand, direct measurement of coenzyme Q10 in a muscle biopsy or in cultured skin fibroblasts, which confirms that the level within the tissue is genuinely low.

A coenzyme Q10 measurement in a simple blood test does NOT rule out this disease: that value depends mainly on diet and does not reflect what the cell is able to produce by itself; some patients with a confirmed mutation have normal blood levels.

Where to start What to do
  • If a child shows progressive loss of coordination when walking, muscle weakness with dark urine after exercise, or seizures with no clear cause, assessment by a paediatric neurology or metabolic diseases unit is advisable, ideally at a Reference Centre, Service or Unit (CSUR) of the Spanish National Health System designated for mitochondrial diseases.
  • If a confirmed genetic diagnosis already exists, follow the high-dose oral coenzyme Q10 regimen indicated by the specialist: it is one of the few mitochondrial diseases in which treatment can modify the clinical course. In this regard, the European Medicines Agency (EMA) has designated ubiquinol as an orphan medicine for the treatment of primary coenzyme Q10 deficiency, a line of research led in Spain by the Biomedical Research Networking Centre on Rare Diseases (CIBERER) of the Carlos III Health Institute, at Pablo de Olavide University/CSIC in Seville.
  • Seek genetic counselling at a clinical genetics unit before future pregnancies if there is already a confirmed case in the family.
  • Patient associations and the Spanish Federation of Rare Diseases (FEDER) can provide guidance on expert centres and support for families.

If left untreated

  • Established neurological or kidney damage does not usually reverse, even if treatment is started later.
  • The response varies greatly depending on the exact gene involved: in general it is better in later-onset forms and in COQ6 gene mutations, and more limited with the COQ8A gene.
  • Without diagnosis or treatment, the disease may follow a progressive course depending on the specific clinical form.
When to stop waiting When to see a doctor

If a child shows progressive loss of coordination when walking, muscle weakness with episodes of dark urine after exertion, or if an infant has several organs affected without a clear diagnosis, assessment by paediatric neurology or a rare metabolic diseases unit is advisable. The sooner the gene involved is identified, the sooner treatment with high-dose coenzyme Q10 can be considered, which in some genetic forms slows the progression of the disease.

Frequently asked questions

Is having cholesterol treated with statins and ‘lowering’ coenzyme Q10 the same as having this disease?

No. Primary coenzyme Q10 deficiency is a genetic disease present from birth, caused by mutations in the COQ genes. The decrease in CoQ10 associated with age or statin treatment is a different phenomenon, much more common and unrelated to these inherited mutations.

Can a blood test for coenzyme Q10 rule out this disease?

No. Diagnosis requires measuring CoQ10 directly in muscle tissue or in cultured skin fibroblasts, together with the corresponding genetic testing. A normal blood value does not rule out the disease, because that result depends mainly on diet rather than on the body’s internal synthesis.

Is there a cure for coenzyme Q10 deficiency?

There is no cure that reverses damage already done. In some genetic forms, high-dose oral coenzyme Q10 supplementation, prescribed by a specialist, can slow the progression of the disease if started early, but the response depends on the specific gene affected, and established neurological or kidney damage generally does not recover.

Is this disease recognised as a rare disease in Spain and the EU?

Yes. Orphanet lists it as a group of disorders with autosomal recessive inheritance, and within Spanish research CIBERER and several public universities maintain active lines of work on diagnosis and treatment.

Sources

By the Bright Naturo editorial team · Updated: September 2026

WhatsApp